Treatment and prevention of signs and symptoms of seasonal and perennial allergic rhinitis. Treatment of signs and symptoms of nasal polyps.
Treatment of persistent bronchial asthma in patients where use of a pressurised inhaler or dry powder formulation is unsatisfactory or inappropriate. Very serious pseudocroup (laryngitis subglottica) in which hospitalisation is indicated.
Treatment of mild, moderate, and severe persistent asthma. (Note: Easyhaler Budesonide is not suitable for the treatment of acute asthma attacks.)
Seasonal and perennial allergic rhinitis and vasomotor rhinitis. Treatment of nasal polyps.
Prevention and treatment of seasonal allergic rhinitis (hay fever).
Treatment of seasonal allergic rhinitis (hayfever) in adults aged 18 years and over. This medicine provides symptomatic relief from nasal congestion, runny nose, sneezing, itchy nose and associated sinus discomfort.
Background: Patients with mild asthma often rely on inhaled short-acting β2-agonists for symptom relief and have poor adherence to maintenance therapy. Another approach might be for patients to receive a fast-acting reliever plus an inhaled glucocorticoid component on an as-needed basis to address symptoms and exacerbation risk.